Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference21 articles.
1. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma;Lele;Gynecol. Oncol.,1989
2. Weekly cis-diamminedichloroplatinum II as induction chemotherapy in recurrent carcinoma of the cervix;Piver;Gynecol. Oncol.,1984
3. 1.5–5 years of uninterrupted cis-diamminedichloroplatinum II chemotherapy for metastatic cervical cancer;Piver;Gynecol. Oncol.,1987
4. Evaluation of bolus cisplatinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix;Rotmensch;Gynecol. Oncol.,1988
5. A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A Gynecologic Oncology Group study;Thigpen;Gynecol. Oncol.,1989
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Marcadores tumorais e a cérvix uterina;Revista Brasileira de Cancerologia;2023-06-14
2. Role of squamous cell carcinoma antigen in prognostication, monitoring of treatment response, and surveillance of locally advanced cervical carcinoma;Journal of Cancer Research and Therapeutics;2023
3. Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial;The Lancet Oncology;2020-12
4. Role of Serum CEA as Tumor Marker for Predicting Presence of Pelvic and Paraaortic Lymph Node Metastasis in SCC of Uterine Cervix;Journal of Cancer Prevention & Current Research;2017-08-02
5. Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy;Journal of Gynecologic Oncology;2013
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3